BSECompany UpdateFundraise3d ago
Colinz Laboratories Ltd
Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Colinz Laboratories Ltd ("Target ....
Colinz Laboratories Ltd has received an open offer from Saffron Capital Advisors Pvt Ltd on behalf of Annjana Dugar, Likhitta Dugar, and Antariksh Dugar to acquire up to 26% of the company's voting share capital for ₹ 54 per share.
BSECompany UpdateResults3d ago
Colinz Laboratories Ltd
Dear Sir,
As required under SEBI(LODR), Regulation, 2015, we are submitting herewith the News Paper Publication , published on 31-7-2026 for the Quarter Ended 30-6-2026. Kindly take ....
Colinz Laboratories Ltd has submitted its audited financial results for the quarter ended June 30, 2026, as required under SEBI (LODR) Regulation, 2015. The results show revenue from operations of Rs. 136.26 crore, net profit of Rs. 290.12 crore, and earnings per share of Rs. 9.53.
BSEResultResults4d ago
Colinz Laboratories Ltd
Please find the attached OUTCOME of the meeting held today dated 30-07-2026 the details of the approved agenda are shown in the OUTCOME.
Colinz Laboratories Ltd held its board meeting on July 30, 2026, and approved several items, including unaudited financial results for the quarter ended June 30, 2026, director's report, management discussion report, corporate governance report, and the appointment of new directors and auditors.
BSEBoard MeetingResults4d ago
Colinz Laboratories Ltd
1. The Board considered and approved Un-Audited Financial Results for the quarter ended 30th June, 2026 as per Regulation 33 (3) of SEBI (Listing Obligations and Disclosure Requirements) ....
Colinz Laboratories Ltd's board meeting outcome: approved un-audited financial results for Q2 2026, appointed new director, approved management discussion report, corporate governance report, and other documents, and finalized 40th AGM date and mode.